Application of peptide receptor radionuclide therapy for gastroenteropancreatic neuroendocrine tumor
10.3760/cma.j.issn.1673-9752.2018.07.022
- VernacularTitle:肽受体放射性核素治疗在胃肠胰神经内分泌肿瘤中的应用进展
- Author:
Huanyu WANG
1
;
Yang LYU
;
Xuefeng XU
Author Information
1. 200032,复旦大学上海医学院
- Keywords:
Neuroendocrine neoplasms;
Pancreatic neoplasms;
Gastric neoplasms;
Colorectal neoplasms;
Peptide receptor radionuclide therapy;
Targeted therapy
- From:
Chinese Journal of Digestive Surgery
2018;17(7):763-766
- CountryChina
- Language:Chinese
-
Abstract:
Peptide receptor radionuclide therapy (PRRT),being investigated as an effective treatment for inoperable gastroenteropancreatic neuroendocrine tumor,has gained much importance in recent years.With increasing data of clinical trials and the exploration of different radionuclides as well as the toxic and side effects,PRRT has developed continuously and play a marked role on the treatment of gastroenteropancreatic neuroendocrine tumor.
